The Doctors Company Acquires ProAssurance Corporation: A Strategic Merger
The Doctors Company has finalized its acquisition of ProAssurance Corporation for $1.3 billion, significantly bolstering its position as a leading medical professional liability insurer in the United States. This merger results in a firm that manages assets valued at $12 billion, serving over 200,000 healthcare professionals and organizations nationwide. The strategic move comes amid ongoing challenges within the U.S. medical malpractice insurance market.
The American Medical Association's Policy Research Perspective from April 2026 highlights a persistent upward trend in medical liability premiums, a pattern that continued for seven years by 2025. According to the data, 39.9% of premiums experienced increases, particularly in states like Pennsylvania and New York. This trend is fueled by the rising severity of claims, with median awards for major malpractice cases more than doubling over the past year, and jury verdicts exceeding $10 million have doubled since 2015. S&P Global reports that payments over $500,000 tied to physicians reached 36.5% in 2024.
In response to these pressures, The Doctors Company, helmed by Chairman and CEO Richard Anderson, strategically acquired ProAssurance by paying a 60% premium over its pre-announcement share price. Based in Napa, California, The Doctors Company acquired all ProAssurance shares at $25 each in cash, leading to ProAssurance's delisting from the New York Stock Exchange. Now a wholly owned subsidiary, The Doctors Company is assessing the most efficient operating structure for the merger.
The acquisition, announced on March 19, 2025, received swift clearance from the Federal Trade Commission concerning antitrust issues by July 2025. Final state-level regulatory compliance approvals in California, Pennsylvania, and Texas paved the way for the deal's closure, securing ProAssurance's shareholder endorsement.
According to AM Best, the deal does not affect the A (Excellent) financial strength ratings of either company, an assurance for policyholders focused on the reliability of claims payments amid the transition. ProAssurance offers capabilities beyond standard physician liability, including products liability for medical technology and life sciences companies, alongside a robust workers' compensation portfolio.
This diversification provides the combined entity with a versatile platform to serve healthcare organizations of all sizes, from individual practitioners to expansive medical systems. The 60% acquisition premium signifies ProAssurance's strategic value in a market where leading insurers heavily influence rate conditions. As claim severity and premium rates continue to rise, the merger offers a unified capital base beneficial for managing large claims and leveraging extensive reinsurance networks to mitigate risks effectively.